Company Overview of Kimmel Cancer Center
Kimmel Cancer Center engages in the discovery and development of new approaches and strategies to prevent, diagnose, monitor, and cure human cancer. The company focuses in translating the discoveries in the genetics, cell biology biochemistry, structural biology pharmacology, and immunology of cancer into modalities for prevention and treatment. It develops solutions for various types of cancer, including brain tumors, breast, colorectal, esophageal, gastrointestinal, gynecologic, head and neck, hematologic, kidney, liver, lung, melanoma/skin, pancreatic, prostate, stomach, and testicular cancers. The organization was founded in 1991 and is based in Philadelphia, Pennsylvania.
233 South 10th Street
BLSB, Room 1050
Philadelphia, PA 19107
Founded in 1991
Key Executives for Kimmel Cancer Center
Similar Private Companies By Industry
|TriLink BioTechnologies, Inc.||United States|
|Genprex, Inc.||United States|
|Matritech, Inc.||United States|
|Traversa Therapeutics, Inc.||United States|
|Coeurative, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Kimmel Cancer Center, please visit www.kimmelcancercenter.com. Company data is provided by Capital IQ. Please use this form to report any data issues.